Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzagolix Phase 2 in Endometriosis
NCT01533532Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of linzagolix in endometriosis (4 arms), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Severity score of the pelvic pain at 12 weeks. Status: completed.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01533532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533532.